{"id":"W3016275215","doi":"10.3390/biom10040605","title":"Sorafenib as an Inhibitor of RUVBL2","year":2020,"lang":"en","type":"article","venue":"Biomolecules","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"Laboratório Nacional de Luz Síncrotron; Canadian Institutes of Health Research; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Centro Nacional de Pesquisa em Energia e Materiais; Fundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Canadian Bureau for International Education","keywords":"Sorafenib; Medicine; Pharmacology; Internal medicine; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001009051,0.0002729961,0.0003769921,0.0001598305,0.0001137041,0.0002925517,0.0002330632,0.000216898,0.0009957422],"category_scores_gemma":[0.00009346224,0.00008314668,0.000264586,0.000100337,0.00009135808,0.0001687177,0.0001160118,0.0004456477,0.0003181627],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002535479,"about_ca_system_score_gemma":0.0001812696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003673751,"about_ca_topic_score_gemma":0.0007605111,"domain_scores_codex":[0.999912,0.00001800683,0.000007236184,0.0000147561,0.00001834078,0.00002962897],"domain_scores_gemma":[0.9999709,0.000005558903,0.000004919442,0.00000238925,0.000005371108,0.00001090991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007160051,0.0002507124,0.0003721778,0.0002154933,0.00004340389,0.0001852386,0.00001973042,0.0006745938,0.9785735,0.0004782765,0.0007098618,0.017761],"study_design_scores_gemma":[0.0005005753,0.00225602,0.002526612,0.00001272313,0.00005682265,0.0009492667,0.0000199085,0.006504459,0.9626229,0.0001446186,0.0243878,0.00001834267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665382,0.01723406,0.009041239,0.0005618581,0.0002106709,0.0001631317,0.0005248272,0.000414814,0.00531128],"genre_scores_gemma":[0.989336,0.003380559,0.002558775,0.0001211129,0.00002309849,0.00004954608,0.0007716246,0.00001340277,0.003745839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009957422,"threshold_uncertainty_score":0.003331125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0383695841829735,"score_gpt":0.312096346759876,"score_spread":0.2737267625769025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}